Evaluation of the Videodrama Therapeutic Device for Children With Autism Spectrum Disorders

NCT06443320 | Recruiting

• 1 other identifier: GHT_CHIRB 20220420
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

Autism spectrum disorder (ASD) is a neurodevelopmental disorder (Valerie, Sperenza, 2009) that begins early in development, characterized by persistent deficits in communication and social interactions across various contexts and restricted, repetitive patterns of behavior, interests, or activities. These symptoms significantly impact social, school/professional functioning, or other important areas and are not better explained by intellectual disability or global developmental delay (American Psychiatric Association, 2013).

Conditions

Autism Spectrum Disorder (ASD)

Keywords

autism; videodrama

Outcome Measures

Primary Outcomes (1)

• Dunn Sensory Profile questionnaire

  Sensory atypicality frequency will be assessed using the Dunn Sensory Profile questionnaire, describing child behavior in various sensory experiences

  9 months

Secondary Outcomes (2)

• Cars-T questionnaire

  9 months

• Sceno Test

  9 months

Study Arms (2)

Group of young ASD patients receiving videodrama sessions and interviews

EXPERIMENTAL

Children participating in videodrama sessions, one per week for 9 sessions.

Other: patient included in experimental groupe will view the video excerpt, a playtime, a drawing activities

Cohort of ASD patients not receiving videodrama but receiving care in participating units

NO INTERVENTION

Patients included in the cohort will be managed as part of their routine care

Interventions

patient included in experimental groupe will view the video excerpt, a playtime, a drawing activities OTHER

Patients included in the videodrama arm will participate in a total of 18 videodrama sessions, with one session per week. Each session will include a patient welcome period, the viewing of a video excerpt (in slow motion or not), a playtime, a drawing period, and a group closing session. For the play and drawing activities, the same materials will be provided in each department and for each group, including small figurines, animals, shapes (such as cubes, triangles, circles), small plush toys, markers, colored pencils, and A4 white sheets of paper.

Group of young ASD patients receiving videodrama sessions and interviews

Eligibility Criteria

• Age: 3 Years - 15 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• Children aged 3 to 15 years.
• Clinically confirmed ASD by a psychiatrist.
• Parental or legal guardian consent for participation.
• Child showing a strong interest in screens and/or video content.
• Ability to tolerate the presence of other children.
• Minimum of 18 video drama sessions.
• Not having benefited from disease care in the past.
• Affiliation to a social security system

You may not qualify if:

• No ASD diagnosis.
• Younger than 3 or older than 15 at the study start.
• No interest in screens or video content.
• Parental or legal guardian refusal for participation.
• Dropping out before completing 18 sessions.
• Patient having benefited a disease care in the past

Sponsors & Collaborators

• Centre Hospitalier Intercommunal Robert Ballanger: lead

Study Sites (1)

CHI Robert Ballanger

Aulnay-sous-Bois, 93600, France

RECRUITING

MeSH Terms

Conditions

Autism Spectrum Disorder; Autistic Disorder

Condition Hierarchy (Ancestors)

Child Development Disorders, Pervasive; Neurodevelopmental Disorders; Mental Disorders

Central Study Contacts

Constance LEMARCHAND

CONTACT

0182372332; constance.lemarchand@ght-gpne.fr

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 30, 2024
• First Posted: June 5, 2024
• Study Start: December 4, 2023
• Primary Completion (Estimated): March 4, 2027
• Study Completion (Estimated): March 4, 2027
• Last Updated: February 6, 2025

Record last verified: 2025-02

Locations

FR (1)